10 completed, 2 terminated, 1 active not recruiting, 1 withdrawn. 6 Not applicable, 3 Phase 1, 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 3, Active not recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
Follow No Evidence of Disease: new trials by email Literature Review of No Evidence of Disease trials Research Report on No Evidence of Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors Best Practice, Exercise Intervention, Laboratory Biomarker Analysis - Cancer Survivor, Central Obesity | Not applicable | Withdrawn | University of Southern California | 2019-03-08 | 2020-12-17 | |
| Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma Best Practice, mySmartCheck, Survey Administration - Dysplastic Nevus, Health Status Unknown | Not applicable | Completed | Rutgers, The State University of New Jersey | 116 | 2018-11-03 | 2022-11-14 |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors Exercise Intervention, Laboratory Biomarker Analysis, Polar heart rate monitor - Cancer Survivor, No Evidence of Disease | Not applicable | Terminated | University of Southern California | 23 | 2017-08-17 | 2025-09-29 |
| Oxybutynin Chloride in Managing Hot Flashes Oxybutynin Chloride, Placebo, Quality-of-Life Assessment - Breast Carcinoma, Ductal Breast Carcinoma In Situ | Phase 3 | Completed | Academic and Community Cancer Research United | 150 | 2016-12-09 | 2020-01-18 |
| Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission Laboratory Biomarker Analysis, pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine, Sargramostim - HER2/Neu Negative, No Evidence of Disease | Phase 1 | Completed | University of Washington | 32 | 2016-09-02 | 2024-09-19 |
| MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer Cytology Specimen Collection Procedure, Laboratory Biomarker Analysis - No Evidence of Disease, Stage II Bladder Cancer | Terminated | University of Southern California | 10 | 2016-03-01 | 2022-08-10 | |
| Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening educational intervention, questionnaire administration, quality-of-life assessment - Anxiety, No Evidence of Disease | Not applicable | Completed | City of Hope Medical Center | 20 | 2014-12-08 | 2018-09-10 |
| Biomarkers in Post-Menopausal Women Receiving Flaxseed Clinical Observation, Flaxseed, Laboratory Biomarker Analysis - No Evidence of Disease | Not applicable | Completed | Roswell Park Cancer Institute | 258 | 2012-12-14 | 2022-05-09 |
| Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants Selenium, Placebo, Laboratory Biomarker Analysis - No Evidence of Disease, Prostate Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 66 | 2011-11-01 | 2014-11-26 |
| Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer questionnaire administration, survey administration, counseling intervention - No Evidence of Disease, BRCA1 Syndrome | Not applicable | Active not recruiting | City of Hope Medical Center | 493 | 2010-12-02 | 2026-10-26 |
| Collection of Bone Marrow From Donors Treated With or Without Filgrastim Bone Marrow Donation, Filgrastim, Laboratory Biomarker Analysis - Healthy Stem Cell Donor, No Evidence of Disease | Phase 3 | Completed | Children's Oncology Group | 13 | 2010-06-14 | 2020-02-26 |
| Study of 9cUAB30 in Healthy Participants Laboratory Biomarker Analysis, Pharmacological Study, Retinoid 9cUAB30 - No Evidence of Disease | Phase 1 | Completed | National Cancer Institute (NCI) | 15 | 2008-08-01 | 2015-06-18 |
| Celecoxib in Decreasing the Damaging Effects of Sunburn in Healthy Volunteers Celecoxib, Laboratory Biomarker Analysis, UV Light Therapy - No Evidence of Disease | Phase 2 | Completed | National Cancer Institute (NCI) | 25 | 2004-03-01 | 2016-12-29 |
| Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers UV Light Therapy, Placebo, Celecoxib - No Evidence of Disease | Phase 2 | Completed | National Cancer Institute (NCI) | 45 | 1999-09-01 | 2016-12-29 |
Breast Neoplasms (3) · Prostatic Neoplasms (2) · Anxiety Disorders (1) · Breast Carcinoma In Situ (1) · Carcinoma, Intraductal, Noninfiltrating (1) · Dysplastic Nevus Syndrome (1) · Hot Flashes (1) · Lung Neoplasms (1) · Melanoma (1) · Obesity (1) · Obesity, Abdominal (1) · Overweight (1) · Sedentary Behavior (1) · Urinary Bladder Neoplasms (1)
Neoplasms (7) · Neoplasms by Site (7) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Breast Diseases (3) · Male Urogenital Diseases (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Body Weight (2) · Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Neoplasms by Histologic Type (2)
Practice Guidelines as Topic (3) · Standard of Care (3) · Celecoxib (2) · Early Intervention, Educational (2) · Methods (2) · Ultraviolet Therapy (2) · Biopsy (1) · Colony-Stimulating Factors (1) · Counseling (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Linseed Oil (1) · Monitoring, Physiologic (1) · Selenium (1) · UAB 30 (1)
National Cancer Institute (NCI) (4) · University of Southern California (3) · City of Hope Medical Center (2) · Academic and Community Cancer Research United (1) · Children's Oncology Group (1) · Roswell Park Cancer Institute (1) · Rutgers, The State University of New Jersey (1) · University of Washington (1)
United States (14)
Alice Pentland (2) · Christina Dieli-Conwright, Ph.D. (2) · Bita Nehoray (1) · Charles Loprinzi (1) · Dan Raz (1) · Howard Bailey (1) · Jacek Pinski (1) · Kari Wisinski (1) · Raymond Bergan (1) · Sharon Manne, PhD (1) · Spencer Rosario, PhD (1) · Stephan A Grupp (1)
PMID 24154719, PMID 34637495, PMID 35261959, PMID 42082270
P30CA014089 (3), P30CA014520 (2), N01CN00033 (1), N01CN35153 (1), N01CN35157 (1), P30CA015083 (1), P30CA060553 (1), P30CA072720 (1), U01CA161809 (1), U10CA098543 (1)